Outcomes Report Michigan’s Transplant Program brings together a team of nationally recognized transplantation surgical and medical experts. In 2022, the lives of 288 patients were changed through transplantation and 30 people gave of themselves to become a living donor. This 2022 Outcomes Report offers a glimpse into the transplantation efforts.
Michigan’s Transplant Program
Reflected by numbers in this report is the expertise of transplantation team. The team is involved in national and local research to bring new medications or techniques to each unique patient. Advancing technology of robot assisted surgeries, the organ care system for hypothermic oxygenated perfusion (HOPE), extracorporeal membrane oxygenation (ECMO), normothermic machine perfusion (NMP) and heart assistive devices support successful transplantation. Yet, none of this would matter without the experts who use the technology. These
are simply highlights of what makes Henry Ford Transplant program comprehensive. Looking beyond southeastern Michigan, the Henry Ford Transplant program has developed a state-wide network of Outreach Clinics. The goal is to reach patients who deserve the best care and expertise available. No matter where in Michigan a patient lives, they have access to the experts for pre- and post-transplantation care, lifesaving care they might not otherwise receive from Michigan’s most comprehensive transplant program.
Liver Transplant A recognized veteran team of hepatologists and liver transplant surgeons bring lifesaving options, including medical and surgical innovations to patients with advanced liver disease and liver failure. The experts of the Henry Ford Liver Transplant program offer both living- and deceased-donor liver transplantation. Few cadaver livers is always a challenge, however the need for liver donation was the impetus for development of The Henry Ford Center for Living Donation, a first in the United States. From a total of 104 transplants, 6 were from living donors.
Patient Survival Rates for Liver Transplant*
% 0
One Year
93.31%
One Year Expected*
93.74%
One Year
93.98%
One Year Expected*
93.66%
10
20
30
40
50
60
70
80
90
100
Graft Survival Rates for Liver Transplant+
Outcomes 3/30/89 Received Medicare approval: Transplants performed First transplant:
1/1/77
104 Median time to transplant < Deceased donor: 98 (7.5 months nationally): 7.0 months Living donor: 6 Transplant rate ~ (expected Total number of program .781, national .787): 1.06 transplants through 2022: 2,364 Waitlist mortality ~ (expected .071, national .071): .069 Deceased donor: 2,226
One Year
92.00%
One Year Expected*
91.78%
One Year
92.59%
One Year Expected*
91.72%
in 2022:
Living donor:
% 0
10
20
30
40
50
60
70
80
90
100
138 henryford.com/transplant | 1
Kidney Transplant Irreversible kidney failure without transplant causes a patient to be dependent on dialysis. Through one of the most experienced programs in the United States, robot-assisted and minimally invasive surgery, the Henry Ford Transplant program’s dedicated team of surgeons and transplant nephrologists change lives. These experts partner to offer a full range of kidney, pancreas and kidney-pancreas transplants, including living donor transplants. One of the longest-running programs, through 2022 there have been 3,886 kidney transplants with 1,318 from living donors.
Patient Survival Rates for Kidney Transplant* One Year
96.65%
One Year Expected*
96.01%
One Year (Deceased Donor)
95.79%
One Year Expected* (Deceased Donor)
94.66% 98.08%
One Year (Living Donor)
98.62%
One Year Expected* (Living Donor) % 0
10
20
30
40
50
60
70
80
90
Outcomes
Graft Survival Rates for Kidney Transplant+
1/4/68 Received Medicare approval: Transplants performed
One Year
93.33%
One Year Expected*
93.62%
One Year (Deceased Donor)
93.07%
One Year Expected* (Deceased Donor)
91.64%
First transplant:
1/1/77
115 Median time to transplant < Deceased donor: 91 (32.9 months nationally): 32.4 months Living donor: 24 Transplant rate ~ (expected Total number of program .264, national .256): .234 transplants through 2022: 3,866 Waitlist mortality ~ (expected .057, national .056): .063 Deceased donor: 2,548 in 2022:
Living donor:
93.35%
One Year (Living Donor)
97.43%
One Year Expected* (Living Donor) % 0
10
20
30
100
40
50
60
70
80
90
100
1,318
Patient Survival Rates for All Pancreas Transplants (PAK, SPK, PTA)* One Year
Pancreas Transplant
One Year Expected* % 0
Nationally recognized as pioneers in Type 1 and Type 2 diabetes management and research, the Henry Ford Division of Endocrinology, Diabetes and Metabolism works closely with nephrologists of the Henry Ford Transplant program to help patients in need of a pancreas transplant. Since 1987, there have been 176 pancreas transplants through 2022.
Outcomes 5/11/87 Received Medicare approval: Transplants performed First transplant: in 2022:
100%
20
95.63% 30
40
50
60
70
80
90
One Year
100%
One Year Expected* % 0
10
20
94.56% 30
40
50
60
70
80
90
100
Patient Survival Rates for SPK (Simultaneous Pancreas-Kidney)*
7/1/99
100%
One Year Expected* % 0
10
20
97.76% 30
40
50
60
70
80
90
100
Patient Survival Rates for PTA (Pancreas Transplant Alone)* One Year
N/A
One Year Expected* % 0
2 | 1-855-85-TRANSPLANT
100
Patient Survival Rates for PAK (Pancreas After Kidney Transplant)*
One Year
4 Waitlist mortality ~ (expected .024, national .026): .084
Total number of program transplants through 2022: 176
10
10
20
N/A 30
40
50
60
70
80
90
100
Outcomes
Lung Transplant As Detroit’s only single- and double-lung transplantation center, the Henry Ford Transplant program has saved the lives 407 people over 28 years, each who were in the hands of a highly skilled team of experts. Transplant pulmonologists along with cardiothoracic surgeons, perform lung transplants for advanced and end-state lung disease. Henry Ford Hospital is also home to experts in extracorporeal membrane oxygenation (ECMO) and support patients who are in critical condition without a ventilator. ECMO allows the body to rest the lungs, reduces complications associated with a ventilator and sustains the patient in better condition leading up to a transplant. ECMO is also used to allow the lungs to heal following transplantation.
First transplant:
10/20/94 Received Medicare approval:
Transplants performed in 2022:
2/1/99
33 Median time to transplant <:
8.9 months Total number of program transplants through Waitlist mortality ~ (expected 2022: 407 .128, national .121): .133
Patient Survival Rates for Lung Transplant* One Year
89.62%
One Year Expected* % 0
10
20
87.85% 30
40
50
60
70
80
90
100
90
100
Graft Survival Rates for Lung Transplant+ One Year
89.48%
One Year Expected* % 0
10
20
87.30% 30
40
50
60
70
80
Outcomes
Heart Transplant A multidisciplinary Advanced Heart Failure team of experts at the Henry Ford Transplant program provide continuity of care with state-of-the-art advanced heart failure care. The team are nationally recognized researchers in heart failure. They bring this expertise to patients with the latest therapeutic regiments and mechanical-assist-device to transplant surgery. For many this includes total artificial heart and ventricular assist devices, and post-surgical management and rehabilitation. In 37 years, 648 patients with heart failure received a heart transplant and a second chance to live. The team’s expertise in mechanical circulatory support devices extended the life of 46 patients with severe heart failure, an option they might not have had in another hospital.
4/23/85 Received Medicare approval: Transplants performed First transplant:
8/2/88
26 Median time to transplant < (4.0 months nationally, 8.1 months regionally): 6.5 months
in 2022:
Total number of program transplants through 2022: 648 Waitlist mortality ~ (expected .070 Number of VADs in 2022: 46 .065, national .062): Mechanical devices at time of transplant #: 96.2%
Patient Survival Rates for Heart Transplant* One Year
90.36%
One Year Expected* % 0
10
20
90.71% 30
40
50
60
70
80
90
100
90
100
Graft Survival Rates for Heart Transplant+
% 0
One Year
89.04%
One Year Expected*
90.04%
10
20
30
40
50
60
70
80
henryford.com/transplant | 3
Intestine/ Multivisceral Transplant The only center in Michigan to offer comprehensive intestine and multivisceral transplantation in adults is at the Henry Ford Transplant program. It is one of only a 10 adult programs in the United States. For people with chronic conditions of the small bowel and those dependent on total parenteral nutrition (TPN), intestine transplant is a viable option. Henry Ford transplant surgeons perform a full array of intestine transplant procedures and for those needing additional abdominal organs, the highly recognized liver and pancreas programs allow for multivisceral transplants. The program continues to grow, performing 47 transplants through 2022.
Outcomes First transplant:
Transplant rate ~ (expected Total number of program .145 transplants through 2022: 47 1.08, national .119): Waitlist mortality ~ (expected Received Medicare .145 approval: 2/8/13 .132, national .119):
Patient Survival Rates for Multivisceral Transplant* One Year
Michelle “Cookie” Crossley, R.N., B.S.N.
80%
One Year Expected* % 0
10
20
81.06% 30
40
50
60
70
80
90
100
Graft Survival Rates for Multivisceral Transplant+ One Year
80%
One Year Expected* % 0
For more information, please contact our outreach coordinators
8/22/10 Median time to transplant < (9.3 months 3.5 months 6 nationally):
Transplants performed in 2022:
10
20
72.34% 30
40
50
60
70
80
90
100
Graph data sourced from: < Patients on the waitlist between 01/01/2017 and 06/30/2022 ~ Patients on the waitlist between 01/01/2021 and 12/31/2022
Mobile Phone: (248) 219-2326 Email: MCROSSL1@hfhs.org
# Patients transplanted between 01/01/2018 and 12/31/2018. Devices include ventricular assist devices (VAD), extracorporeal membrane oxygenation (ECMO), intra-aortic balloon pump (IABP), and total artificial heart (TAH)
Christina Somers, R.N., B.S.N.
* Estimated probability of surviving at one year, for patients receiving their first transplant between 01/01/2020 and 03/12/2020 and between 06/13/2020 and 06/30/2022; and at three years, for patients receiving their first transplant between 07/01/2017 and 12/31/2019
Mobile Phone: (313) 622-4352 Email: CSOMERS1@hfhs.org
Katie Dandron, R.N.
Mobile Phone: (313) 353-3990 Email: KDANDRO1@hfhs.org
On call 24/7 Download the Henry Ford Transplant program app For iPhone, iPad and Android platform devices. You can download the app via the Apple® App Store or Google Play at no charge. Simply search “Henry Ford Transplant” and download this convenient tool today. 4 | 1-855-85-TRANSPLANT
+ Estimated probability of surviving with a functioning graft at one year, for patients receiving their first transplant between 01/01/2020 and 03/12/2020 and between 06/13/2020 and 06/30/2022; and at three years, for patients receiving their first transplant between 07/01/2017 and 12/31/2019 Source: Scientific Registry of Transplant Recipients, Center and OPO-specific Reports, based on data available April 30, 2023, released July 6, 2023.